E
Helius Medical Technologies, Inc. HSDT
$0.40 -$0.01-2.44%
Recommendation
Sell
Prev Close
$0.41
Volume
112,680
Avg Vol (90D)
3,236,917
Market Cap
$2.51M
Dividend & Yield
--
52-Week Range
$0.373 - $7.19
P/E (TTM)
--
EPS (TTM)
-$5.76
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Maxim Group Remains a Hold on Helius Medical Technologies (HSDT)
3/28/2025 - TipRanks Financial Blog
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Short Interest Up 247.1% in March
3/27/2025 - Ticker Report
Helius Medical Technologies (NASDAQ:HSDT) Posts Earnings Results, Misses Expectations By $0.09 EPS
3/25/2025 - Ticker Report
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface ( BCI ) Technology Private Subsidiary
3/13/2025 - Globe Newswire
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS ) Device
3/11/2025 - Globe Newswire
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy on Gait Deficit Improvement in Multiple Sclerosis from the PoNS Therapeutic Experience Program Study
1/22/2025 - Globe Newswire
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants ...
1/22/2025 - GuruFocus
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market
1/22/2025 - Globe Newswire
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study ...
1/21/2025 - GuruFocus
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
1/21/2025 - Globe Newswire
Helius Medical Technologies, Inc. Announces First PoNS System Sale to VA Healthcare SystemOn December 23, 2024, Helius Medical Technologies, Inc. (NASDAQ:HSDT) disclosed its successful sale of the first Portable Neuromodulation Stimulator (PoNS) Syst
12/25/2024 - Ticker Report
Helius Announces First Portable Neuromodulation Stimulator (PoNS ) System Sale to the Veterans Affairs (VA) Healthcare System
12/23/2024 - Globe Newswire
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Sees Large Drop in Short Interest
12/17/2024 - Ticker Report
Helius Medical Technologies Reports Q3 2024 Earnings
11/23/2024 - TipRanks Financial Blog
Helius Medical Technologies Initiates Strategic Alternatives to Maximize Stockholder ValueNEWTOWN, Pa., Nov. 18, 2024 / Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced on November 18, 2024, the initiation of a process to explore strategic a
11/20/2024 - Ticker Report
Helius Medical Explores Strategic Alternatives Amid Challenges
11/18/2024 - TipRanks Financial Blog
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS ) Device
11/18/2024 - Globe Newswire
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives
11/18/2024 - GuruFocus
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives
11/18/2024 - Globe Newswire
Hudson Bay Capital Management LP Acquires New Stake in Helius Medical Technologies Inc
11/9/2024 - GuruFocus
Reviewing Gadsden Properties (OTCMKTS:GADS) & Helius Medical Technologies (NASDAQ:HSDT)
11/5/2024 - Ticker Report
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
10/18/2024 - Globe Newswire
Helius Medical announces CMS reimbursement payment determination
10/14/2024 - TipRanks Financial Blog
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS ) Controller and Mouthpiece
10/14/2024 - Globe Newswire
Income Statement
Total Revenue (TTM)
$520.00K
EBITDA (TTM)
-$13.80M
EBIT (TTM)
-$13.86M
Net Income (TTM)
-$11.74M
Balance Sheet
Total Assets (Q)
$3.54M
Total Debt (Q)
$12.00K
Total Liabilities (Q)
$2.48M
Book Value Per Share (Q)
$0.2841
Cash Flow
Cash from Operations (TTM)
-$11.04M
Cash from Investing (TTM)
-$5.00K
Cash from Financing (TTM)
$6.95M
Net Change in Cash (TTM)
-$4.09M
Filings
Filing Date
Tuesday, March 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
0.82
7-Day Total Return
-2.82%
30-Day Total Return
-25.79%
60-Day Total Return
-45.15%
90-Day Total Return
-11.54%
Year to Date Total Return
-43.05%
1-Year Total Return
-93.83%
2-Year Total Return
-96.77%
3-Year Total Return
-99.77%
5-Year Total Return
-99.92%
52-week Low
Oct 15, 2024 - $0.373
52-week High
Apr 03, 2024 - $7.19
Valuation
Market Cap
$2.51M - Nano Cap
Enterprise Value
$1.44M
Price/Sales (TTM)
2.96
Price/Book (Q)
1.44
Dividends and Shares
Shares Outstanding
3.75M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
heliusmedical.com
Phone Number
215 944 6100
Address
642 Newtown Yardley Road
Newtown, PA 18940
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological... more
NASDAQ 04/03/2025 3:50PM Eastern Quotes delayed
Weiss Ratings